Cannabis Science and Technology to Host Special Veterans Day Webcast
Cannabis Science and Technology®, is thrilled to be hosting “From Post-Traumatic Stress to Post-Traumatic Growth: How Medical Cannabis Is Helping Veterans with PTSD” webcast on Veterans Day, November 11, 2020 at 11am EST | 8am PST | 4pm GMT | 5pm CET.
To honor our veterans, Cannabis Science and Technology®, is excited to be hosting “From Post-Traumatic Stress to Post-Traumatic Growth: How Medical Cannabis Is Helping Veterans with PTSD” webcast on Veterans Day, November 11, 2020 at 11am EST. This event will highlight how cannabis helped improve the quality of life for our veterans suffering from various mental health conditions, such as post-traumatic stress disorder (PTSD). Dr. Marion McNabb will be presenting her findings from the 2019 Veterans’ Health and Medical Cannabis Study. The research study highlights the veterans who reported that cannabis has been helpful for treating PTSD.
The event will also feature a special panel discussion organized by veteran and advocate Stephen Mandile. The panelists chiming in with their unique experiences with medical cannabis include veterans Dan Moynihan, Daniel Vela, and Hether Zeckser.
Cannabis Science and Technology®’s Veterans Day event will be presented in partnership with Cannabis Center of Excellence, Cannabis Advancement Series, and Joint Venture & Co.
Register for free at http://www.cannabissciencetech.com/cst_w/veterans.
Is Cannabis a Solution to the Opioid Crisis?
January 23rd 2025In this research overview, Ruth Fisher, PhD, explores how cannabis has shown promise in helping individuals reduce opioid use, potentially decreasing overdose deaths. Though its impact on chronic pain and opioid reduction remains evident, limitations exist and flaws in methodologies in ecological studies complicate conclusions.
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Kahn
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
